Bioventus Inc. — Director's Dealing 2021

Apr 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bioventus Inc. (BVS)
CIK: 0001665988
Period of Report: 2021-02-11

Reporting Person: Anglum Gregory O. (SVP & General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-11	Common Stock	P	6000	$13.00	Acquired	6000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-01	Restricted Stock Units	$	A	96876	Acquired		Class A Common Stock (96876)	Direct
2021-04-01	Stock Options	$15.23	A	9100	Acquired	2031-03-31	Class A Common Stock (9100)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F2: The restricted stock units vest on April 1, 2022 and have no expiration date.

F3: The stock option vests in four equal annual installments beginning on April 1, 2022.